- Chai Discovery Announces $70 million Series A To Transform . . .
The fundraise was led by Menlo Ventures, including investment from their Anthology Fund, a joint partnership with Anthropic to identify and back promising AI companies, with participation from new
- Series A - Chai Discovery
Chai Discovery has raised $70M in additional funding in a Series A financing round The fundraise was led by Menlo Ventures, including investment from their Anthology Fund, a joint partnership with Anthropic to identify and back promising AI companies, with participation from new investors Yosemite, DST Global Partners, SV Angel, Avenir, DCVC
- Chai Discovery Raises $70M in Series A Funding - finsmes. com
Chai Discovery, a San Francisco, CA-based AI company that predicts and reprograms the interactions between biochemical molecules to accelerate life-changing therapeutics, raised $70m in Series A
- AI Startup Chai Discovery Raises $70 Million to Design Life . . .
The round, led by Menlo Ventures through its partnership with AI company Anthropic, included participation from DST Global Partners, Yosemite, and existing investors Thrive Capital and OpenAI The funding brings Chai's total capital raised to $100 million since its founding in 2024
- AI-Driven Biotech Chai Discovery Raises $70M Backed by OpenAI
Chai Discovery raises $70M Series A led by Menlo Ventures to expand AI-powered molecular design Backers include OpenAI, Thrive Capital, Anthropic’s Anthology Fund, and biotech veteran Mikael Dolsten Chai‑2 model achieves near-20% antibody design hit rate, accelerating drug discovery timelines
- OpenAI-backed Chai raises $70mn for AI-driven drug discovery
OpenAI-backed start-up Chai Discovery has raised $70mn, valuing the group at about $550mn, as investors bet on the potential for artificial intelligence to speed up drug discovery and tackle disease
- Chai Discovery Raises $70M for AI-Driven Drug Discovery
The biotech world is buzzing — and for good reason Chai Discovery, a cutting-edge AI-driven biotech company, has just secured a massive $70 million Series A funding round, signaling a game-changing moment in the future of drug discovery Backed by Giants The round was led by Menlo Ventures, in partnership with Anthropic, and supported by…
|